ClinicalTrials.gg
Not yet recruitingNCT06953401Updated May 1, 2025

Muscle Activity of the Gastrocnemius and Soleus Muscles by Surface Electromyography.

An observational study in Muscle Activity, Electromyography and Lower Limb, sponsored by University of Extremadura. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-01.

Sponsored by University of Extremadura · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This cross-sectional, comparative study aims to evaluate and compare the surface electromyographic (sEMG) activity of the gastrocnemius (medial and lateral) and soleus muscles during static and dynamic contraction tasks. Participants will perform three tests-resting state, isometric, concentric, and eccentric contraction, and dynamic gait-with bilateral measurements. A subgroup analysis will examine muscle activity variations based on foot posture, using the Foot Posture Index (FPI). The study uses the validated mDurance® sEMG system to obtain objective data under controlled lab conditions. The findings will enhance understanding of the functional role of each muscle and could inform rehabilitation and injury prevention strategies.

02

Conditions studied

  • Muscle Activity
  • Electromyography
  • Lower Limb
03

In context

Lead sponsor

University of Extremadura is the lead sponsor of 48 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of healthy young adults enrolled in undergraduate programs at the Centro Universitario de Plasencia, University of Extremadura (Spain). Participants will be recruited through internal communication channels at the university. All participants will voluntarily agree to take part in the study and sign an informed consent form. Eligibility criteria include individuals aged 18 to 30 years, with no history of recent musculoskeletal injuries or surgeries in the lower limbs, and able to perform the required physical tasks without restriction. Subjects with foot postural alterations will also be included for later comparison with subjects without foot postural alterations.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 30 years.
  • No history of severe musculoskeletal disorders in the lower limbs.
  • No recent surgery or injury in the last 6 months.
  • No dermatological conditions affecting electrode placement.
  • Not allergic to adhesives.
  • Ability to perform the task without limitation.

    •. No high-intensity exercise in the 12 hours before testing

  • Ability to provide and complete the assessment

Exclusion criteria

Exclusion Criteria:

  • Reduced lower limb mobility.
  • Neuromuscular or skeletal conditions affecting the calf region.
  • Intense physical activity 12 hours before testing.
  • Lack of .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No

Interventions

  • OtherMuscle contraction protocol for electromyographic assessment

    Participants will perform a set of standardized lower limb muscle contractions (isometric, concentric, and eccentric) involving the gastrocnemius and soleus muscles while lying on an examination table and in standing position both static and dynamic as well as walking. Surface electromyography (mDurance® sEMG system) will be used to record muscle activation during each phase. The task is designed for physiological measurement only and does not constitute a therapeutic intervention. Protocol includes 3 trials per muscle and side, using standardized test conditions.

06

What researchers measure

Primary outcomes

  1. Muscle activation, microvolts (μV)

    Muscle activation (μV) as recorded by mDurance® sEMG system during the contraction protocol (soleus vs. gastrocnemius).

    Time frame: Baseline or Day 1. During a single assessment session (~30 minutes).

Secondary outcomes

  1. RMS (root mean square) and peak EMG signal values (μV)

    RMS and peak EMG signal values (μV): average muscle activity measured by RMS (root mean square) and maximum voluntary contraction by peak activation. Comparison of Medial vs. Lateral Gastrocnemius Activation. Comparison of Medial vs. Lateral Gastrocnemius Activation

    Time frame: Baseline or Day 1. During the same assessment session

  2. Differences in muscle activity by contraction type (μV)

    Differences in muscle activity by contraction type (μV): Effect of contraction type (isometric/concentric/eccentric) on muscle activity. Comparison of Medial vs. Lateral Gastrocnemius Activation

    Time frame: Baseline or Day 1. Immediately after the execution of each contraction type during the session

  3. Activity differences by foot posture (pronated, neutral, supinated)

    Muscle activation of the gastrocnemius and soleus will be compared based on foot posture (pronated, neutral, or supinated). This aims to identify whether foot type influences activation patterns.

    Time frame: Baseline or Day 1. Immediately after foot posture assessment during the same session

  4. Correlation with physical activity level Physical Activity Questionnaire (IPAQ-short version)

    Correlation with physical activity level (IPAQ-short version): Correlation with sociodemographic and anthropometric factors (age, sex, BMI, activity level). Self-reported questionnaire assessing physical activity over the last 7 days. Physical activity is categorized as Low, Moderate, or High based on total MET-minutes/week. Sitting time is recorded separately as an indicator of sedentary behavior.

    Time frame: Baseline or Day 1. Collected at baseline before EMG assessment

07

Study locations

1 site
  • Centro Universitario de Plasencia
    Plasencia, Cáceres 10600, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2025; primary completion for Nov 2025, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2025
First posted
May 1, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
Nov 1, 2025
CompletionEst.
Dec 1, 2025
Last update
May 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06953401
Lead sponsor
University of Extremadura
Responsible party
Alejandro Caña Pino (Investigator, University of Extremadura) — Principal investigator
First posted
May 1, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Nov 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
May 1, 2025

Study contacts

Raquel MA Dra. Raquel Mayordomo Acevedo, PhD
Contact
rmayordo@unex.es
927427000
María Victoria CM María Victoria Cáceres Madrid, PhD
principal investigator · Departamento de Enfermería. Centro Universitario de Plasencia. Universidad de Extremadura
Olga LR Olga López Ripado, MSc
principal investigator · Departamento de Anatomía, Biología Celular y Zoología. Centro Universitario de Plasencia. Universidad de Extremadura
Alejando CP Alejandro Caña Pino, PhD
principal investigator · Departamento de Terapéutica Médico-Quirúrgica. Facultad de Enfermería y Terapia Ocupacional. Universidad de Extremadura
Marina FJ Fontán Jiménez, PhD
principal investigator · Departamento de Enfermería. Centro Universitario de Plasencia. Universidad de Extremadura
Raquel MA Raquel Mayordomo Acevedo, PhD
study director · Departamento de Anatomía, Biología Celular y Zoología. Centro Universitario de Plasencia. Universidad de Extremadura

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion